Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
Details for Australian Patent Application No. 2006284841 (hide)
International Classifications
Event Publications
3 April 2008 PCT application entered the National Phase
PCT publication WO2007/027761 Priority application(s): WO2007/027761
4 October 2012 Alteration of Name
The name of the applicant has been altered to The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services; Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006284845-Multi-rotor wind turbine supported by continuous central driveshaft
2006284832-NMR device for detection of analytes involving magnetic particles
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser